US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

19.14

-0.2098-1.08%

Post-market: 19.140.00000.00%19:30 EDT

Volume:127.96K

Turnover:2.44M

Market Cap:112.91M

PE:- -

High:19.20

Open:19.04

Low:18.87

Close:19.35

52wk High:21.50

52wk Low:14.38

Shares:5.90M

Float Shares:5.90M

Volume Ratio:2.99

T/O Rate:2.17%

Dividend:0.71

Dividend Rate:3.73%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Wuxi Biologics (Cayman) Stock Advances 1.5% in Hong Kong

WuXi Biologics Makes Forbes China ESG 50 List for 2026

Is Innovent Biologics (SEHK:1801) Fairly Valued On LP 003 China BLA Progress?

Simply Wall St.

CSPC Pharmaceutical Gets Breakthrough Therapy Designation for Lung Cancer Drug

MT Newswires Live

Cspc Pharmaceutical Says Sys6010 Granted Breakthrough Therapy Designation by NMPA

CSPC Pharma's Novel Drug SYS 6010 Receives Breakthrough Therapy Designation in China for Advanced Non-Small Cell Lung Cancer

CSPC Pharmaceutical - Sys6010 Granted Breakthrough Therapy Designation by Nmpa in China for Nsclc

THOMSON REUTERS

CSPC Pharmaceutical Group Stock Sheds 1.9% in Hong Kong, Underperforms Competitors

Jefferies Reaffirms Bullish Stance on AKESO, Sets Price Target at HK$226

Jefferies Highlights Positive HARMONi-2 Results for AKESO, Reaffirms Buy Rating with HK$226 Target

Record WCLC Data From Chinese Innovators Signals Clear Recovery for CRO/CDMO Sector, Wall Street Takes Notice

Hong Kong Stocks Recover as WCLC Conference Sparks Biotech Rally, While US AI Slowdown Calls Raise Questions

Southbound Capital Flow: Net Buying Reaches HK$4.471 Billion, with Heavy Inflows into AI Hardware Stocks and Z.AI (02513) Attracting Over HK$1.2 Billion

CSPC Pharmaceutical Group Stock Rallies 1.8% in Hong Kong

Wuxi Biologics (Cayman) Stock Advances 4.6% in Hong Kong

JPMorgan Highlights Strong Overall Survival Data from Akeso's HARMONi-2 Trial, Reaffirms Overweight Rating

Big Pharma is Pouring Billions into China's Biotechs

Innovent's Enlarged Cash Holdings, Investment Fair Value Could Boost Earnings

Citi Highlights Akeso's HARMONi-2 Overall Survival Edge, Reaffirming Buy Rating on Differentiation

HK Stocks in Focus: Innovative Drug Sector Surges on WCLC Data Boost, Analysts See Value After Pullback

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/KURE/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":19.14,"timestamp":1790971200000,"preClose":19.3498,"halted":0,"volume":127957,"hourTrading":{"tag":"盘后","latestPrice":19.14,"preClose":19.14,"latestTime":"19:30 EDT","volume":8,"amount":153.12,"timestamp":1790983803066,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.010842489328054955,"floatShares":5899036,"shares":5899036,"eps":0,"marketStatus":"Market Closed","change":-0.2098,"latestTime":"10-02 16:00:00 EDT","open":19.04,"high":19.2,"low":18.87,"amount":2436278.887525,"amplitude":0.017054,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":19.3498,"sharesOutstanding":4750002,"nav":19.06,"aum":112453199.16,"dividendRate":0.037315,"bidAskSpread":0.008807,"postHourTrading":{"tag":"盘后","latestPrice":19.14,"preClose":19.14,"latestTime":"19:30 EDT","volume":8,"amount":153.12,"timestamp":1790983803066,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.9854503635447447,"impliedVol":0.1722,"impliedVolPercentile":0.3665},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5899036,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.9854503635447447,"shares":5899036,"dividePrice":0.7142,"high":19.2,"amplitude":0.017054,"preClose":19.3498,"low":18.87,"week52Low":14.3797,"pbRate":"--","week52High":21.5,"institutionHeld":0,"latestPrice":19.14,"eps":0,"divideRate":0.037315,"volume":127957,"delay":0,"ttmEps":0,"open":19.04,"prevYearClose":17.04,"prevWeekClose":18.72,"prevMonthClose":19.25,"prevQuarterClose":19.25,"fiveDayClose":18.72,"twentyDayClose":18.91,"sixtyDayClose":16.4655},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667606198","title":"Wuxi Biologics (Cayman) Stock Advances 1.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2667606198","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667606198?lang=en_us&edition=fundamental","pubTime":"2026-09-16 16:32","pubTimestamp":1789547520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rose 1.5% to 49.94 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.2% to 24713.78.This was the stock's third consecutive day of gains.Wuxi Biologics  Inc. closed 8.3% below its 52-week high of HK$54.45, which the company reached Aug. 26.Trading volume totaled 30.0 million shares, compared to the 50-day average of 36.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0039217434.USD","LU0417516902.SGD","LU0516422366.SGD","LU0359201612.USD","02269","LU0516422952.EUR","LU0029874061.USD","LU0516423174.USD","LU0348827113.USD","LU0819121731.USD","LU1242518857.USD","LU0708995583.HKD","LU3063872942.SGD","LU0051755006.USD","LU0572944931.SGD","KURE","LU0348825331.USD","LU0326950275.SGD","BK1589","LU0359202008.SGD","LU0823426308.USD","LU0320764599.SGD","LU0417516738.SGD","LU0588546209.SGD","IE00B0JY6N72.USD","LU0856984785.SGD","LU0561508036.HKD","BK1521","LU0052750758.USD","LU1688375341.USD","LU1880383366.USD","LU0456846285.SGD","LU0307460666.USD","LU1794554557.SGD","LU1720050803.USD","LU2039709279.SGD","LU0140636845.USD","SG9999002463.SGD","LU0327786744.USD","LU0043850808.USD","LU0128526141.USD","LU0516423091.SGD","LU0516422440.USD","LU0979878070.USD","BK1610","SG9999002562.SGD","BK1141","LU0823426480.USD","LU0181495838.USD","LU1242518931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667605410","title":"WuXi Biologics Makes Forbes China ESG 50 List for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667605410","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667605410?lang=en_us&edition=fundamental","pubTime":"2026-09-16 16:03","pubTimestamp":1789545789,"startTime":"0","endTime":"0","summary":"WuXi Biologics makes Forbes China ESG 50 list for 2026WuXi Biologics was named to the 2026 Forbes China ESG 50 list, cited for Green CRDMO execution and ESG digital innovation.Forbes China highlighted","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL6XMv3r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","LU1242518857.USD","LU0823426308.USD","LU0417516738.SGD","BK1141","LU0029874061.USD","LU0516423091.SGD","LU0516423174.USD","LU0417516902.SGD","LU2039709279.SGD","LU0359202008.SGD","LU0561508036.HKD","BK1589","02269","LU0043850808.USD","IE00B0JY6N72.USD","LU1688375341.USD","LU0307460666.USD","BK1610","SG9999002562.SGD","LU0819121731.USD","LU3063872942.SGD","LU0708995583.HKD","SG9999002463.SGD","LU0326950275.SGD","LU0051755006.USD","LU0181495838.USD","LU0588546209.SGD","LU0348825331.USD","LU0327786744.USD","LU0979878070.USD","LU0359201612.USD","LU0348827113.USD","LU0823426480.USD","LU0320764599.SGD","LU0516422952.EUR","LU1242518931.SGD","LU0516422440.USD","LU0572944931.SGD","LU0856984785.SGD","LU0039217434.USD","LU0140636845.USD","LU1720050803.USD","LU0052750758.USD","LU1794554557.SGD","LU1880383366.USD","BK1521","LU0516422366.SGD","LU0456846285.SGD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668822938","title":"Is Innovent Biologics (SEHK:1801) Fairly Valued On LP 003 China BLA Progress?","url":"https://stock-news.laohu8.com/highlight/detail?id=2668822938","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668822938?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:26","pubTimestamp":1789485964,"startTime":"0","endTime":"0","summary":"The National Medical Products Administration has accepted LongBio Pharma’s Biologics License Application for LP-003, supported by Innovent Biologics (SEHK:1801) subsidiary Altruist Biologics, marking China’s first anti-IgE BLA for seasonal allergic rhinitis.\nFor investors tracking Innovent Biologics, the latest regulatory milestone lands after a mixed stretch in the market, with the share price slipping 1.9% over the last session and 5.2% across the week, yet recording a 26.9% 90 day share...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/is-innovent-biologics-sehk1801-fairly-valued-on-lp-003-china","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/is-innovent-biologics-sehk1801-fairly-valued-on-lp-003-china","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2097828631.EUR","LU0244354667.USD","HK0000165453.HKD","LU2242644610.SGD","BK1589","LU1188198961.HKD","LU0463099449.HKD","LU1831875114.USD","LU1969619763.USD","LU2328871848.SGD","KURE","BK4097","LU2065732104.USD","LU0149534421.HKD","LU2097828557.USD","LU0455707207.USD","PRGS","LU0326950275.SGD","LU2488822045.USD","LU2097828805.USD","LU2097828474.EUR","LU2097828714.EUR","LU0502904849.HKD","LU0607220059.USD","BK1583","BK1161","DCF","01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644981","title":"CSPC Pharmaceutical Gets Breakthrough Therapy Designation for Lung Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644981","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644981?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:49","pubTimestamp":1789472968,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group  said its SYS6010 drug has received Breakthrough Therapy Designation from China's National Medical Products Administration.The designation covers the treatment of recurrent or metastatic non-squamous non-small cell lung cancer with actionable genomic alteration-negative status in patients whose disease has progressed after prior immunotherapy and platinum-based chemotherapy, according to a Tuesday Hong Kong exchange filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1152091168.USD","01093","LU0140636845.USD","LU1226287792.SGD","LU1813983027.USD","IE00BZ08YR35.GBP","LU0314109678.HKD","HK0000165453.HKD","LU0072913022.USD","IE00BZ08YS42.EUR","LU1226287529.USD","LU0315179316.USD","LU1328277881.USD","BK1515","LU0880133367.SGD","IE00B5MMRT66.SGD","LU1226288170.HKD","IE0008368742.USD","IE0008369823.USD","LU1226288253.USD","LU1993786604.SGD","LU0501845795.SGD","IE00B031HY20.USD","LU0067412154.USD","KURE","IE00B543WZ88.USD","IE00BZ08YT58.USD","LU1960683339.HKD","LU0326950275.SGD","LU1152091754.HKD","SG9999004220.SGD","LU1008478684.HKD","LU2039709279.SGD","BK1191","BK1521","LU1951186391.HKD","LU1226287875.USD","LU1807302812.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667646466","title":"Cspc Pharmaceutical Says Sys6010 Granted Breakthrough Therapy Designation by NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2667646466","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667646466?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:28","pubTimestamp":1789468089,"startTime":"0","endTime":"0","summary":"Sept 15 (Reuters) - CSPC PHARMACEUTICAL <1093.HK>::*SYS6010 GRANTED BREAKTHROUGH THERAPY DESIGNATION BY NMPA IN CHINA FOR NSCLC*Further company coverage: 1093.HK* ((Reuters.Briefs@thomsonreuters.com;)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nRSDbrrGqm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1152091754.HKD","BK1515","IE00B543WZ88.USD","LU1152091168.USD","IE00B5MMRT66.SGD","LU0072913022.USD","LU1226288170.HKD","LU0140636845.USD","LU0880133367.SGD","LU1008478684.HKD","LU1813983027.USD","LU1226287529.USD","LU0314109678.HKD","IE00BZ08YR35.GBP","BK1191","IE00BZ08YT58.USD","LU1226287875.USD","LU0315179316.USD","LU0326950275.SGD","IE0008368742.USD","HK0000165453.HKD","LU2039709279.SGD","LU0501845795.SGD","IE0008369823.USD","SG9999004220.SGD","IE00B031HY20.USD","LU1226288253.USD","LU0067412154.USD","KURE","LU1960683339.HKD","LU1951186391.HKD","01093","LU1328277881.USD","LU1993786604.SGD","IE00BZ08YS42.EUR","BK1521","LU1807302812.USD","LU1226287792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167369366","title":"CSPC Pharma's Novel Drug SYS 6010 Receives Breakthrough Therapy Designation in China for Advanced Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1167369366","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167369366?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:10","pubTimestamp":1789467046,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its innovative drug candidate, SYS 6010, has been included in the Breakthrough Therapy Designation list by China's National Medical Products Administration...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0067412154.USD","IE00BZ08YT58.USD","LU1152091754.HKD","LU1226287792.SGD","BK1521","IE0008369823.USD","LU0326950275.SGD","LU0140636845.USD","IE0008368742.USD","BK1515","IE00B5MMRT66.SGD","LU1328277881.USD","IE00B543WZ88.USD","HK0000165453.HKD","LU1226287875.USD","LU1226288253.USD","LU0880133367.SGD","LU0072913022.USD","LU1226287529.USD","LU1813983027.USD","BK1191","LU1960683339.HKD","LU2039709279.SGD","LU1807302812.USD","LU0315179316.USD","LU1152091168.USD","LU1226288170.HKD","LU1951186391.HKD","IE00BZ08YR35.GBP","KURE","SG9999004220.SGD","01093","LU0314109678.HKD","IE00BZ08YS42.EUR","LU1008478684.HKD","LU0501845795.SGD","IE00B031HY20.USD","LU1993786604.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667645268","title":"CSPC Pharmaceutical - Sys6010 Granted Breakthrough Therapy Designation by Nmpa in China for Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2667645268","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667645268?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:02","pubTimestamp":1789466529,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570BT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B543WZ88.USD","LU0501845795.SGD","LU1813983027.USD","LU1008478684.HKD","LU1152091754.HKD","HK0000165453.HKD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","LU0067412154.USD","LU1328277881.USD","IE0008369823.USD","BK1515","01093","LU1807302812.USD","LU0326950275.SGD","BK1521","BK1191","LU1960683339.HKD","LU0140636845.USD","LU1226287792.SGD","LU1993786604.SGD","LU1951186391.HKD","SG9999004220.SGD","IE00B5MMRT66.SGD","LU1226288170.HKD","LU1152091168.USD","LU0315179316.USD","LU2039709279.SGD","LU0880133367.SGD","LU1226287875.USD","LU0314109678.HKD","IE0008368742.USD","KURE","LU0072913022.USD","LU1226287529.USD","IE00B031HY20.USD","LU1226288253.USD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667610979","title":"CSPC Pharmaceutical Group Stock Sheds 1.9% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667610979","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667610979?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:33","pubTimestamp":1789461180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. slid 1.9% to 8.70 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 24667.24.CSPC Pharmaceutical Group Ltd. closed 21% short of its 52-week high of HK$10.96, which the company achieved Jan. 30.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 1.0%, SSY Group Ltd. rose 2.1%, and United Laboratories International Holdings Ltd. fell 2.8%.Trading volume totaled 51.4 million shares, compared to the 50-day average of 102.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","SG9999004220.SGD","KURE","BK1521","LU0501845795.SGD","LU1008478684.HKD","LU1328277881.USD","IE00B031HY20.USD","IE0008368742.USD","BK1191","LU1226288253.USD","LU2039709279.SGD","LU1226287875.USD","IE00BZ08YS42.EUR","LU0880133367.SGD","IE00BZ08YR35.GBP","LU0315179316.USD","LU1226287529.USD","LU1951186391.HKD","LU0072913022.USD","IE00B5MMRT66.SGD","01093","LU1226287792.SGD","IE00B543WZ88.USD","LU1993786604.SGD","LU0326950275.SGD","LU1960683339.HKD","IE00BZ08YT58.USD","LU0067412154.USD","LU1152091168.USD","LU1152091754.HKD","LU1226288170.HKD","BK1515","LU0140636845.USD","LU1813983027.USD","LU0314109678.HKD","LU1807302812.USD","IE0008369823.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152384150","title":"Jefferies Reaffirms Bullish Stance on AKESO, Sets Price Target at HK$226","url":"https://stock-news.laohu8.com/highlight/detail?id=1152384150","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152384150?lang=en_us&edition=fundamental","pubTime":"2026-09-15 12:21","pubTimestamp":1789446061,"startTime":"0","endTime":"0","summary":"Jefferies has released a research note indicating that the H-2 study of AKESO's (09926) Ivonescimab has yielded favorable outcomes. The data showed that the interim overall survival (OS) endpoint...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348766576.USD","LU1961090484.USD","LU2476274720.SGD","LU0417516738.SGD","LU0348827113.USD","LU0417516571.SGD","09926","IE00BPRC5H50.USD","LU0348784397.USD","LU0417516902.SGD","LU1720050803.USD","EWH","LU0348767384.USD","LU2399975544.HKD","LU0348783233.USD","BK1574","LU0634319403.HKD","IE00B543WZ88.USD","LU2778985437.USD","LU1794554557.SGD","BK1161","LU0561508036.HKD","LU2488822045.USD","LU0540923850.HKD","LU2476274308.USD","LU0348735423.USD","IE00B5MMRT66.SGD","KURE","LU0348825331.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126314596","title":"Jefferies Highlights Positive HARMONi-2 Results for AKESO, Reaffirms Buy Rating with HK$226 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1126314596","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126314596?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:00","pubTimestamp":1789437625,"startTime":"0","endTime":"0","summary":"Jefferies has released a research report indicating that AKESO (09926) achieved positive results from its HARMONi-2 study of Ivonescimab. The data showed that the interim overall survival (OS)...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","BK1574","09926","LU0348827113.USD","LU2476274720.SGD","LU1961090484.USD","LU0348735423.USD","LU0540923850.HKD","LU0348783233.USD","LU2778985437.USD","LU0348767384.USD","LU0417516571.SGD","BK1161","IE00BPRC5H50.USD","LU1794554557.SGD","LU0417516902.SGD","IE00B5MMRT66.SGD","LU0634319403.HKD","LU2399975544.HKD","LU0561508036.HKD","LU0348784397.USD","LU2476274308.USD","LU1720050803.USD","LU2488822045.USD","LU0417516738.SGD","KURE","LU0348825331.USD","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184266083","title":"Record WCLC Data From Chinese Innovators Signals Clear Recovery for CRO/CDMO Sector, Wall Street Takes Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=1184266083","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184266083?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:54","pubTimestamp":1789430067,"startTime":"0","endTime":"0","summary":"The 2026 World Conference on Lung Cancer (WCLC) taking place in Seoul from September 12-15 has become a major catalyst for Chinese innovative drug developers, with a record number of clinical data...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","LU1226287792.SGD","IE0008369823.USD","VXUS","IE00BZ08YR35.GBP","LNGR","LU0880133367.SGD","LU1152091754.HKD","LU2039709279.SGD","IE00BZ08YS42.EUR","KCAI","LU0315179316.USD","LU1226288170.HKD","LU0501845795.SGD","IE0008368742.USD","LU0140636845.USD","BK1539","BK1119","LU1328277881.USD","BK1191","02889","IE00B031HY20.USD","LU1951186391.HKD","LU1226287875.USD","MEDX","BK1521","LU1960683339.HKD","LU1226287529.USD","159992","HK0000165453.HKD","KURE","BK1144","LU1813983027.USD","06871","BK1161","BK1147","BK4585","BK4139","IE00BZ08YT58.USD","LU1807302812.USD","SG9999004220.SGD","BK1183","LU1226288253.USD","LU1152091168.USD","01911","LU0072913022.USD","LU0326950275.SGD","BK1515","LU1008478684.HKD","LU0314109678.HKD","IE00B5MMRT66.SGD","BK4588","CDMO","IE00B543WZ88.USD","01093","LU0067412154.USD","02238","BK1574","IBBQ","LU1993786604.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128920905","title":"Hong Kong Stocks Recover as WCLC Conference Sparks Biotech Rally, While US AI Slowdown Calls Raise Questions","url":"https://stock-news.laohu8.com/highlight/detail?id=1128920905","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128920905?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:50","pubTimestamp":1789390244,"startTime":"0","endTime":"0","summary":"Hong Kong stocks showed resilience on Wednesday, dipping in early trading before recovering to close 0.45% higher despite worrying inflation signals from the US. Core CPI rose 0.3% month-on-month,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1719994722.HKD","LU0640798160.USD","BK1589","BK1221","LU1115378108.SGD","06690","BK1557","LU0228659784.USD","LU1770034418.SGD","LU0417516738.SGD","02688","IE00BPRC5H50.USD","BK1583","LU0173614495.USD","00135","LU2778985437.USD","IE00BZ08YR35.GBP","LU0868486357.SGD","KCAI","KURE","LU0593848301.USD","BK1570","LU0348735423.USD","LU0417516902.SGD","LU0651946864.USD","LU2476274308.USD","ARTY","IE0008369823.USD","LU1515016050.SGD","LU0469268626.HKD","IE00BYV24P56.USD","BK1574","LU1119993845.HKD","BK1521","IE00BZ08YS42.EUR","LU0287142896.SGD","LU1981816686.USD","IE00B543WZ88.USD","IE00BGHQDM52.EUR","LU2328871848.SGD","09969","IE00BZ08YT58.USD","LU1808992512.USD","LU2279701549.SGD","LU0890818403.SGD","MEDX","BK1607","AIPO","IE00B29SXG58.USD","06978","LU0821914370.USD","LU0431992006.USD","LU1655091616.SGD","LU0828237510.HKD","BK1588","CHAT","IE00BVYPNP33.GBP","IE00BMCWC346.EUR","LU2048586759.USD","LU0205439572.USD","LU0588546209.SGD","VTHR","LU1051768304.USD","LU0862451753.SGD","LU1969619763.USD","BK1214","IE00B5MMRT66.SGD","159992","06160","LU1224709979.USD","IE0034224299.USD","IBBQ","IE00B031HY20.USD","LNGR","VXUS","AGIX","LU0307460666.USD","LU0737861699.HKD","BK1161","LU1303224171.USD","LU1251922891.USD","BK1566","IE0008368742.USD","BK1500","BK4588","LU1048596156.SGD","01193","BK1528","LU0348825331.USD","BK4585","QTOC","LU0877626530.USD","IE00BVYPNQ40.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145133908","title":"Southbound Capital Flow: Net Buying Reaches HK$4.471 Billion, with Heavy Inflows into AI Hardware Stocks and Z.AI (02513) Attracting Over HK$1.2 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1145133908","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145133908?lang=en_us&edition=fundamental","pubTime":"2026-09-14 17:52","pubTimestamp":1789379545,"startTime":"0","endTime":"0","summary":"On September 14, the Hong Kong stock market saw southbound capital record a net purchase of HK$4.471 billion. The Shanghai-Hong Kong Stock Connect posted net buying of HK$1.671 billion, while the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1046422090.SGD","LU0890818403.SGD","LU0791590937.USD","LU0634319403.HKD","LU0348735423.USD","LU1794554557.SGD","LU0572940350.SGD","LU0128525689.USD","VTHR","HK0000320223.HKD","BK1117","HK0000320264.USD","02513","LU2399975544.HKD","LU1206782309.USD","LU0029875118.USD","KURE","LU0320764755.SGD","IE0003895053.USD","LU0791591158.USD","LU0862451753.SGD","LU2488822045.USD","LU1961090484.USD","LU0543330483.HKD","LU0417516902.SGD","LNVGY","LU1366334578.USD","AGIX","LU0310800965.SGD","LU0540923850.HKD","LU2476274720.SGD","LU0862451837.USD","IE00B543WZ88.USD","LU0348784397.USD","LU0348766576.USD","LU1235295612.USD","TCHI","LU0052756011.USD","LU0672654166.SGD","CHAT","IE0034224299.USD","ARTY","BK1506","06869","BK1526","LU0348825331.USD","LU0348767384.USD","LU0264606111.USD","80992","BK1607","LU2242644610.SGD","HK0000306701.USD","BK1193","BK1161","AIPO","QTOC","BK1574","LU0593848301.USD","LU0128522157.USD","09926","SG9999006597.SGD","LU0348827113.USD","LU1366334651.USD","IE00B5MMRT66.SGD","HK0000306685.HKD","00992","LU1808992512.USD","IE00BPRC5H50.USD","LU0417516571.SGD","LU0417516738.SGD","LU2778985437.USD","LU0588546209.SGD","LU0049112450.USD","LU0561508036.HKD","LU1785774172.SGD","LU0048580855.USD","BK1523","BK1149","LU1267930227.SGD","LU1720050803.USD","LU0307460666.USD","LU0370786039.SGD","IE0032431581.USD","LU0572939691.SGD","IE00B0JY6N72.USD","LU0348783233.USD","LU2476274308.USD","LU0972618739.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667965915","title":"CSPC Pharmaceutical Group Stock Rallies 1.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2667965915","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667965915?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:32","pubTimestamp":1789374720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. rose 1.8% to 8.87 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24917.60.The stock's rise snapped a five-day losing streak.CSPC Pharmaceutical Group Ltd. closed 19% below its 52-week high of HK$10.96, which the company reached Jan. 30.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. rose 4.3%, SSY Group Ltd. rose 1.0%, and United Laboratories International Holdings Ltd. rose 2.3%.Trading volume totaled 95.9 million shares, compared to the 50-day average of 103.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0315179316.USD","LU1226287792.SGD","LU1960683339.HKD","LU1807302812.USD","LU0501845795.SGD","LU1328277881.USD","LU1993786604.SGD","LU1813983027.USD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","LU1152091754.HKD","LU1008478684.HKD","IE00B031HY20.USD","LU1226287875.USD","BK1191","KURE","LU0140636845.USD","LU1226288253.USD","IE0008368742.USD","BK1521","IE00B5MMRT66.SGD","LU1226288170.HKD","LU1951186391.HKD","HK0000165453.HKD","LU0880133367.SGD","LU1226287529.USD","LU0326950275.SGD","IE0008369823.USD","IE00B543WZ88.USD","LU0314109678.HKD","SG9999004220.SGD","BK1515","IE00BZ08YS42.EUR","LU0067412154.USD","LU1152091168.USD","01093","LU0072913022.USD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667913659","title":"Wuxi Biologics (Cayman) Stock Advances 4.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2667913659","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667913659?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:30","pubTimestamp":1789374600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rose 4.6% to 49.14 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24917.60.The stock's rise snapped a three-day losing streak.Wuxi Biologics  Inc. closed 9.8% short of its 52-week high of HK$54.45, which the company reached Aug. 26.Trading volume totaled 33.6 million shares, compared to the 50-day average of 37.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","LU0561508036.HKD","LU0856984785.SGD","LU0359202008.SGD","IE00B0JY6N72.USD","LU1880383366.USD","LU0708995583.HKD","LU0128526141.USD","LU1720050803.USD","BK1141","LU0140636845.USD","LU0417516902.SGD","LU0043850808.USD","LU0516422952.EUR","LU0456846285.SGD","LU0819121731.USD","LU0307460666.USD","LU0051755006.USD","LU0456827905.SGD","LU0572944931.SGD","LU0417516738.SGD","LU0516423091.SGD","LU1242518931.SGD","BK1521","LU0516422440.USD","SG9999002562.SGD","LU0516423174.USD","LU1242518857.USD","LU1688375341.USD","LU0029874061.USD","02269","LU0181495838.USD","LU0823426480.USD","BK1589","LU2039709279.SGD","LU0320764599.SGD","LU0359201612.USD","LU0823426308.USD","LU0052750758.USD","SG9999002463.SGD","LU0039217434.USD","BK1610","LU0348735423.USD","LU3063872942.SGD","KURE","LU1794554557.SGD","LU0588546209.SGD","LU0326950275.SGD","LU0979878070.USD","LU0516422366.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160507484","title":"JPMorgan Highlights Strong Overall Survival Data from Akeso's HARMONi-2 Trial, Reaffirms Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1160507484","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160507484?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:14","pubTimestamp":1789373662,"startTime":"0","endTime":"0","summary":"JPMorgan has released a research report following Akeso's (09926) updated overall survival (OS) data from its HARMONi-2 trial, noting that the results are notably robust. The hazard ratio (HR) stands...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2381873111.SGD","LU1668664300.SGD","IE000BZT7R73.USD","LU2237443622.USD","LU0265550946.USD","LU2746668974.SGD","LU1119994496.HKD","LU2505996681.GBP","LU0267386448.USD","LU1363072403.SGD","BK4534","LU0971096721.USD","LU2778985437.USD","LU2476274720.SGD","LU0634319403.HKD","LU0323591593.USD","LU0417516571.SGD","LU0417516738.SGD","LU1366333091.USD","LU0348735423.USD","LU2023250330.USD","JPMO","LU0976567544.SGD","BK4566","LU0048584097.USD","BK4585","LU0211327993.USD","IE00BJLML261.HKD","LU2237443465.HKD","LU1116320737.USD","LU2168564149.EUR","LU0859254822.USD","LU0106261372.USD","LU1794554557.SGD","LU2746668461.USD","LU0211326839.USD","FNCL","IE00BN8TJ469.HKD","IE000SO60NU8.SGD","LU1145028129.USD","BK4516","LU1244550221.USD","IE00BHPRN162.USD","BK4533","09926","TRUF","LU2430703095.HKD","LU0310799852.SGD","LU1496350171.SGD","LU1670628061.USD","LU1548497426.USD","LU2106854487.HKD","LU1961090484.USD","LU1084165304.USD","LU1496350502.SGD","JPM","LU1720051108.HKD","LU0348827113.USD","LU0496365809.HKD","LU2488822045.USD","LU2476274308.USD","LU0320765646.SGD","LU2552382058.USD","LU2756315318.SGD","LU2430703178.SGD","LU0256863902.USD","LU1261432733.SGD","KURE","LU2552382215.SGD","LU0345770993.USD","LU2023250843.SGD","LU0417516902.SGD","LU2023250504.SGD","LU2592432038.USD","LU0820562030.AUD","LU1974910355.USD","IE00BLSP4239.USD","LU0203345920.USD","LU0208291251.USD","IE00B775SV38.USD","IE00BPRC5H50.USD","LU2054465674.USD","LU0348783233.USD","IE00B1XK9C88.USD","LU1894683264.USD","IE000MB6IJN5.SGD","LU0348767384.USD","LU2213496289.HKD","VFH","LU0868494617.USD","LU0689472784.USD","LU0345770308.USD","LU0964807845.USD","LU1670627923.USD","BK4550","IE00BYXW3230.USD","LU0265550359.USD","LU0006306889.USD","IE00BZ1G4Q59.USD","LU0070302665.USD","LU1244550494.USD","IE00B1BXHZ80.USD","LU0256863811.USD","LU0157215616.USD","LU1914381329.SGD","LU0211328371.USD","IE00BK4W5M84.HKD","LU2430703251.USD","LU1116320901.HKD","LU0561508036.HKD","LU2168564495.EUR","IE00B543WZ88.USD","LU2237443549.SGD","LU2417539215.USD","LU2456880835.USD","LU0942090050.USD","LU1267930490.SGD","LU0211326755.USD","LU2236285917.USD","LU0868494708.USD","LU1551013342.USD","LU2237443382.USD","BK4588","LU0683600562.USD","LU1280957306.USD","IE00BDCRKT87.USD","LU0540923850.HKD","IE00BKDWB100.SGD","LU0234572021.USD","LU1720051017.SGD","LU1162221912.USD","LU0348766576.USD","LU2242649171.HKD","SG9999002232.USD","LU0238689110.USD","LU1720050803.USD","BK4207","LU0203347892.USD","LU0234570918.USD","UYG","JPO","LU1894683348.USD","LU2756315664.SGD","LU0345769128.USD","LU0345769631.USD","IE00BLSP4452.SGD","LU2237443895.HKD","LU0943347566.SGD","LU2211815571.USD","IE00BJTD4N35.SGD","SG9999002224.SGD","LU2237443978.SGD","LU0251132253.USD","LU2552382132.HKD","LU2244417387.USD","LU1032466523.USD","IE00BJTD4V19.USD","LU2505996509.AUD","IE0000B7K699.USD","IE000F7OJYX1.SGD","LU1064131342.USD","BK1574","LU2168564222.USD","LU0882574139.USD","TFNS","IE00BWXC8680.SGD","BK1161","KBWB","LU0211331839.USD","LU2357305700.SGD","IE00BFXG1179.USD","IE00BKVL7J92.USD","LU0820561909.HKD","FTXO","BK4581","IE000M9KFDE8.USD","LU0348825331.USD","LU1988902786.USD","IE00BDRTCR15.USD","IE00BK4W5L77.USD","LU1551013425.SGD","LU2357627491.SGD","LU0820561818.USD","LU2168564065.EUR","IE0034235188.USD","LU2462157665.USD","XLF","BK4504","LU2399975544.HKD","IYG","LU2168563687.JPY","IE00BBT3K403.USD","LU0320765489.SGD","LU0417517546.SGD","LU0640476718.USD","LU0215105999.USD","LU0187121727.USD","IXG","IE000WAW04H5.SGD","LU0787776722.HKD","LU1244550577.SGD","LU1366192091.USD","LU1629891620.HKD","LU0149725797.USD","IE0034235295.USD","LU0348784397.USD","LU2264538146.SGD","LU0106831901.USD","IE00B3S45H60.SGD","IYF","LU0170899867.USD","IE00B5MMRT66.SGD","IE0034235303.USD","LU1917777945.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667656927","title":"Big Pharma is Pouring Billions into China's Biotechs","url":"https://stock-news.laohu8.com/highlight/detail?id=2667656927","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667656927?lang=en_us&edition=fundamental","pubTime":"2026-09-14 15:59","pubTimestamp":1789372740,"startTime":"0","endTime":"0","summary":"China's biotech industry has become as much a challenger to America's technological leadership as China's artificial intelligence upstarts.Big Pharma firms have cut license deals worth tens of billion","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1610","LU0405327494.USD","BK0028","SG9999002463.SGD","LU0067412154.USD","LU0051755006.USD","BK1141","IE0002270589.USD","BK1515","BK4534","LU0320765992.SGD","LU2242646821.SGD","LU0819121731.USD","LU0588546209.SGD","LU2417539215.USD","IE00BPRC5H50.USD","LU0456846285.SGD","LU0823416689.USD","LU0979878070.USD","LU1960683339.HKD","LU2488822045.USD","LU1929549753.HKD","BK1576","LU0029874061.USD","LU1969619763.USD","LU0348827113.USD","BK4139","FTXH","IE00B19Z3581.USD","LU0634319403.HKD","LU2112291526.USD","LU1226287792.SGD","LU1585245621.USD","LU1941712264.USD","IE00BZ08YR35.GBP","LU2023250843.SGD","LU1974910355.USD","LU0965509101.SGD","BMY","LU0039217434.USD","LU1688375341.USD","LU0109394709.USD","LU1116320737.USD","LU2125909593.SGD","LU0823426480.USD","LU1236620750.USD","SG9999014575.USD","09926","LU0607220059.USD","RXL","LU1008478684.HKD","LU0069063385.USD","LU0128525929.USD","LU1580142542.USD","KURE","LU1868837136.USD","LU0052750758.USD","GSK","LU2148510915.USD","LU1328277881.USD","LU1934455277.USD","LU1868837300.USD","LU0477156953.USD","IE0009355771.USD","IXJ","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0348767384.USD","LU1323610961.USD","LU1720050803.USD","LU1894683264.USD","LU0889565916.HKD","SG9999015341.SGD","LU0267386448.USD","SMMT","LU1162221912.USD","LU1670711040.USD","LU1829250122.USD","LU2328871848.SGD","LU1997245094.SGD","LU2236285917.USD","LU1236620834.HKD","AZN","LU0648001328.SGD","LU1813983027.USD","LU1670711123.USD","LU0237698245.USD","PPH","IE00B3T34201.USD","BK4599","LU0307460666.USD","BK1191","BMED","LU1226287875.USD","LU1188198961.HKD","LU0208291251.USD","LU0572944931.SGD","IE00BLSP4239.USD","LU0861579265.USD","LU2361044865.SGD","LU0203345920.USD","LU1267930573.SGD","LU0265550359.USD","LU0856984785.SGD","LU1923622614.USD","SBHMY","LU1997245177.USD","LU1571399168.USD","LU2461242641.AUD","IE00B0JY6N72.USD","LU2106854487.HKD","LU0516423091.SGD","LU0348766576.USD","GSKH","PAWZ","BK0239","LU2237443622.USD","LU1961090484.USD","IE00BJT1NW94.SGD","LU0289739343.SGD","LU0321505868.SGD","LU3063872942.SGD","LU2089984988.USD","LU0225771236.USD","SG9999002224.SGD","LU1989772840.SGD","LU2242644610.SGD","LU0315179316.USD","LU0432979614.USD","IE00BFXG1179.USD","LU0306807586.USD","XLV","BK4568","LU1807302812.USD","LU1993786604.SGD","SG9999013999.USD","IE0008368742.USD","LU2097828805.USD","LU1074936037.SGD","LU0456827905.SGD","LU0058720904.USD","01177","BK0012","LU2778985437.USD","SGXZ57979304.SGD","LU0405327148.USD","LU1069347547.HKD","LU0463099449.HKD","LU1066051225.USD","LU0314109678.HKD","LU2360032135.SGD","BK1589","LU0327786744.USD","LU1699723380.USD","FHLC","LU0326950275.SGD","LU0880133367.SGD","LU1820825898.SGD","BK4007","BK4533","LU0130517989.USD","LU1116320901.HKD","LU1023059063.AUD","LU1868836914.USD","LU2125154778.USD","LU0320765489.SGD","LU1997244956.HKD","BK0188","LU2433249047.HKD","LU0511384066.AUD","LU1035773651.USD","IE000M9KFDE8.USD","LU0348784397.USD","LU1057294990.SGD","LU0181495838.USD","LU1291159041.SGD","LU2476274308.USD","BK4559","LU0417516902.SGD","SG9999001440.SGD","LU0516422366.SGD","LU1983299246.USD","LU0114720955.EUR","LU1868836757.USD","IE00B19Z3B42.SGD","LU1831875114.USD","LU1430594728.SGD","LU2324357040.USD","LU1989771016.USD","LU2237443465.HKD","OZEM","LU1242518857.USD","LU0348783233.USD","LU1061106388.HKD","LU2456880835.USD","LU1146622755.USD","GSK.UK","LU2097828631.EUR","LU1328615791.USD","LU0980610538.SGD","LU2133065610.SGD","BK1583","LU1066053197.SGD","LU1037948897.HKD","BK1574","IE00B5MMRT66.SGD","LU2596442595.SGD","LU0359202008.SGD","LU0310800379.SGD","LU0006306889.USD","LU0455707207.USD","LU0070302665.USD","LU0708995583.HKD","LU1883839398.USD","SG9999002562.SGD","LU0417516571.SGD","LU2097828474.EUR","IE00BSNM7G36.USD","LU0130102774.USD","BK0060","LU0244354667.USD","LU0289739699.SGD","LU0456855351.SGD","LU2242652126.USD","HRTS","LU2462157665.USD","01276","LU0502904849.HKD","LU1226287529.USD","LU0306806265.USD","LU1917777945.USD","IE0008369823.USD","LU0043850808.USD","LU1880383366.USD","LU2491049909.HKD","IE00B1BXHZ80.USD","BK0183","LU0140636845.USD","LU1226288253.USD","IE00B543WZ88.USD","LU1261432733.SGD","BK4581","IE00BBT3K403.USD","LU2468319806.SGD","LU2495084118.USD","LU1781817850.SGD","LU1941712348.USD","TRUH","LU0124676726.USD","SG9999014559.SGD","SG9999011175.SGD","SG9999014567.USD","LU2039709279.SGD","LU0348825331.USD","BK4588","LU0708994859.HKD","LU1934455194.USD","LU2097828557.USD","IE00B031HY20.USD","LU0225284248.USD","LU0882574055.USD","LU1152091754.HKD","LU0417516738.SGD","IE00BZ08YS42.EUR","SG9999001176.USD","LU2097828714.EUR","GDOC","LU0029864427.USD","BK1161","LU0859254822.USD","01801","LU0203347892.USD","LU0122379950.USD","LU2491050071.SGD","LU1951186391.HKD","LU0170899867.USD","VHT","IE00BLSP4452.SGD","IHE","LU0096364046.USD","BK0196","IE00BJJMRZ35.SGD","LU0098860793.USD","LU0106261372.USD","IE0002141913.USD","LU0320764599.SGD","SG9999002232.USD","MRK","LU1152091168.USD","IE00BZ08YT58.USD","LU1670710661.SGD","LU0823426308.USD","LU2237443549.SGD","LU2237443978.SGD","LU2399975544.HKD","LU1655091616.SGD","LU0238689110.USD","LU0149534421.HKD","LU1066051811.HKD","LU0965508806.USD","LU0540923850.HKD","LU1242518931.SGD","LU2289578879.USD","LU0266013472.USD","LU1064131003.USD","LU0985320562.USD","LU1718418525.SGD","LU0320765646.SGD","LU2580892862.HKD","LU0234572021.USD","LU2125909247.SGD","LU0689626769.HKD","LU1868836591.USD","LU0942090050.USD","BK4548","LU2023250504.SGD","LU0061475181.USD","LU0985481810.HKD","LU1093756168.USD","BK4532","LU1894683348.USD","600276","LU0472753341.HKD","LU0868494708.USD","LU0965509010.AUD","LU0057025933.USD","LU1066051498.USD","BK4516","IE00BFTCPJ56.SGD","LU0516423174.USD","LU0128526141.USD","JDOC","LU2361045086.USD","LU1794554557.SGD","SG9999015358.SGD","IE00BN8TJ469.HKD","SG9999014542.SGD","LU1934455863.HKD","LU0211331839.USD","LU2125154935.USD","IYH","LU1093756325.SGD","LU1226288170.HKD","LU0516422952.EUR","LU0516422440.USD","LU2237443895.HKD","LU0501845795.SGD","LU0072913022.USD","09688","LU1201861249.SGD","LU1064130708.USD","LU1989772923.USD","BK4526","LU0868494617.USD","ZLAB","02269","LU2237443382.USD","AZNH","LU0561508036.HKD","LU0348735423.USD","SG9999001176.SGD","WXXWY","LU0265550946.USD","LU2580892789.USD","PFE","LU0359201612.USD","SG9999003800.SGD","BK4550","BK4592","BK4531","BK1521","LU0965509283.SGD","LU0289961442.SGD","LU1037948541.HKD","HK0000165453.HKD","LU1032466523.USD","LU2357627491.SGD","LU2361044949.HKD","SG9999004220.SGD","LU1670710588.SGD","LU1255011170.USD","LU2491050154.USD","LU0321505439.SGD","BK4585","01093","LU2476274720.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667656833","title":"Innovent's Enlarged Cash Holdings, Investment Fair Value Could Boost Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2667656833","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667656833?lang=en_us&edition=fundamental","pubTime":"2026-09-14 15:40","pubTimestamp":1789371600,"startTime":"0","endTime":"0","summary":"0740 GMT - Innovent Biologics' enlarged cash holdings and investment fair-value gains could bolster its earnings over 2026-2028, say DBS Group Research analysts in a note. The Chinese biopharmaceutical company's fair value of its investments such as wealth products increased in 1H, while its total cash is expected to rise to 29 billion yuan in December 2028 from 20 billion yuan in December 2025, they say. DBS raises its annual interest income projections by 76% over 2026-2028. It also lifts its 2026-2028 earnings estimates by 6%-21%. DBS reiterates its buy rating and 144.00 Hong Kong dollar target price on the stock. Shares are up 3.4% at HK$96.75.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1831875114.USD","LU2097828557.USD","LU2097828714.EUR","LU0244354667.USD","LU2097828474.EUR","KURE","LU0607220059.USD","LU0326950275.SGD","LU0149534421.HKD","LU0455707207.USD","LU1188198961.HKD","BK1583","BK1589","LU0502904849.HKD","LU2097828805.USD","LU2488822045.USD","BK1161","LU2328871848.SGD","01801","LU2242644610.SGD","LU1969619763.USD","LU2097828631.EUR","HK0000165453.HKD","LU0463099449.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104674198","title":"Citi Highlights Akeso's HARMONi-2 Overall Survival Edge, Reaffirming Buy Rating on Differentiation","url":"https://stock-news.laohu8.com/highlight/detail?id=1104674198","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104674198?lang=en_us&edition=fundamental","pubTime":"2026-09-14 15:32","pubTimestamp":1789371143,"startTime":"0","endTime":"0","summary":"Citi has released a research report noting that the interim analysis from AKESO's (09926) HARMONi-2 trial demonstrates a meaningful overall survival benefit for ivonescimab as a first-line...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156953.USD","LU1668664300.SGD","BK4585","LU0130517989.USD","LU1074936037.SGD","C","LU1244550577.SGD","IE00B543WZ88.USD","LU2360032135.SGD","IE00B5MMRT66.SGD","BK1161","LU0130102774.USD","LU0348825331.USD","LU0106831901.USD","LU0052756011.USD","BK1574","LU0162691827.USD","LU0348783233.USD","LU1506573853.SGD","LU2399975544.HKD","LU1201861249.SGD","LU1244550221.USD","BK4534","LU0170899867.USD","LU1720050803.USD","LU2125154935.USD","LU2476274720.SGD","BK4588","IE00BSNM7G36.USD","09926","LU0561508036.HKD","LU0634319403.HKD","BK4566","LU0072461881.USD","LU0417516902.SGD","LU0320765646.SGD","LU0348766576.USD","LU1244550494.USD","LU0128525689.USD","BK4207","TFNS","LU2778985437.USD","LU0348827113.USD","LU0098860793.USD","LU2417539215.USD","IE00BPRC5H50.USD","IYF","BK4559","LU0980610538.SGD","LU0203345920.USD","LU0648001328.SGD","LU2488822045.USD","KURE","LU0348784397.USD","LU2456880835.USD","LU0348767384.USD","LU1144417596.USD","LU1961090484.USD","LU2462157665.USD","LU1791807156.HKD","LU0203347892.USD","LU2125154778.USD","LU2236285917.USD","LU0310800965.SGD","LU0417516738.SGD","LU1366192091.USD","LU0314106906.USD","LU2476274308.USD","FTXO","LU0540923850.HKD","LU0417516571.SGD","LU1162221912.USD","LU1267930227.SGD","BK4504","LU0348735423.USD","LU1794554557.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184182375","title":"HK Stocks in Focus: Innovative Drug Sector Surges on WCLC Data Boost, Analysts See Value After Pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=1184182375","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184182375?lang=en_us&edition=fundamental","pubTime":"2026-09-14 14:00","pubTimestamp":1789365620,"startTime":"0","endTime":"0","summary":"Shares of innovative drug companies in Hong Kong are trading broadly higher on Tuesday, fueled by bullish clinical data presented at a major oncology conference and renewed optimism around policy...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348825331.USD","01801","09969","LU0417516738.SGD","LU1794554557.SGD","LU1831875114.USD","LU0607220059.USD","VXUS","BK1574","LU2778985437.USD","KURE","LU0348783233.USD","KCAI","LU0417516571.SGD","LU2399975544.HKD","LU2476274720.SGD","BK1589","LU0348767384.USD","LU1969619763.USD","LU2328871848.SGD","06978","01177","BK1191","IE00BPRC5H50.USD","LU0326950275.SGD","01530","IE00BZ08YS42.EUR","LU0348827113.USD","LU0348766576.USD","LU0502904849.HKD","LU0540923850.HKD","LU1188198961.HKD","LU2097828631.EUR","IE00B543WZ88.USD","IE00BZ08YT58.USD","LU2097828805.USD","LU2097828714.EUR","LU0455707207.USD","MEDX","BK1521","LU0463099449.HKD","LU2476274308.USD","LU2097828557.USD","BK1593","IE00BZ08YR35.GBP","09926","LU1720050803.USD","LU1961090484.USD","BK4588","LU0149534421.HKD","HK0000165453.HKD","BK1161","LU0244354667.USD","LU2097828474.EUR","LU2488822045.USD","BK4585","LU0417516902.SGD","LU0348784397.USD","LU0561508036.HKD","BK1515","BK1583","LNGR","LU0634319403.HKD","LU2242644610.SGD","IE00B5MMRT66.SGD","159992","LU0348735423.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}